Products

What will AGI do for Bosentan?

This classification denotes an endothelin receptor antagonist with the molecular formula C27H29N5O6S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q326023R30, chemically known as 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2-bipyrimidin)-4-yl)benzenesulfornamide but generally known as bosentan, which bears US NIH Compound Identifier 104865. Bosentan most often comes in basic and hydrate forms. European Medicines Agency schedules Bosentan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05877MIG. World Health Organization schedules bosentan in its Anatomical Therapeutic Chemical (ATC) Classification. BOSENTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bosentan under HS 29350090 and SITC 51580. As of Q4 2014, BOSENTAN remains the US FDA Preferred Term for this commodity. Bosentan bears US NLM identifiers UMLS ID C0252643 and NCI Concept Code C47417. SMILES: S(=O)(=O)(NC1NC(NC(OCCO)C1OC1C(OC)CCCC1)C1NCCCN1)C1CCC(C(C)(C)C)CC1.